1 day Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has ra…
Nasdaq 100 · Pharmaceuticals · Science
X